Last reviewed · How we verify
NCT03315403: CAPTAIN
Quantitative Polymerase Chain Reaction for Improved Detection of Pneumococci in CAP "CAPTAIN"
trial testing LytA targeted quantitative polymerase chain reaction (qPCR) in Pneumonia, Pneumococcal in 922 participants. Completed in 12 March 2020.
12 March 2020
Quick facts
| Lead sponsor | Medical Center Alkmaar |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 922 |
| Start date | 5 April 2018 |
| Primary completion | 12 March 2020 |
| Estimated completion | 12 March 2020 |
| Sites | 2 locations across Netherlands |
Drugs / interventions tested
- LytA targeted quantitative polymerase chain reaction (qPCR)
Conditions studied
- Pneumonia, Pneumococcal — all drugs for Pneumonia, Pneumococcal →
- Community-acquired Pneumonia — all drugs for Community-acquired Pneumonia →
Sponsor
Medical Center Alkmaar
Who can join
18 and older, any sex, with Pneumonia, Pneumococcal or Community-acquired Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the added diagnostic value of a quantitative polymerase chain reaction targeting the lytA gene in detecting pneumococci in patients with community-acquired pneumonia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03315403
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Medical Center Alkmaar trials
Trials by the same sponsor.
- NCT02657473 — Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis · Phase 2, PHASE3 · completed
- NCT01964495 — Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03315403 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical Center Alkmaar
- Last refreshed: 8 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03315403.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing